HS

Hifzur R Siddique

Aligarh Muslim University, University of Southern California, CSIR-Indian Institute of Toxicology Research, University of Minnesota

ORCID iD 0000-0001-8736-0487
Follow

About

Resistance to therapy severely limits the effectiveness of chemotherapy drugs in treating cancer. For Advanced Cancer, the progression of tumors to the state of chemoresistance, the paucity of knowledge about the mechanism of chemoresistance and lack of therapeutic molecule/s are major stumbling blocks in the management and treatment of disease in cancer patients. Primary or acquired drug resistance remains a fundamental cause of therapeutic failure in cancer therapy. Ever since I have started my research life, I have been trying to understand how different cells, gene, proteins, might contribute to initiation, progression, and Chemoresistance of cancer. Unraveling drug resistance mechanisms and discovery of new therapeutic molecule/s are not only facilitating rational treatment strategies to overcome existing limitations in therapeutic efficacy but will enhance biomarker discovery and the development of companion diagnostics.

Employment

  • Aligarh Muslim University Senior Assistant Professor
    2018 - Present
  • Aligarh Muslim University Assistant Professor
    2017 - 2018
  • University of Southern California Research Associate
    2013 - 2016
  • University of Minnesota Senior Research Associate
    2012 - 2013
  • University of Minnesota Hormel Fellow
    2010 - 2012
  • University of Wisconsin Madison Research Associate
    2008 - 2010

Education

  • CSIR-Indian Institute of Toxicology Research Ph.D.
    2003 - 2008
  • Aligarh Muslim University M.Sc.
    1998 - 2000

Projects & Funding

Projects & funding information is unavailable.

Publications (107)